Transcription factor expression and cellular redox in immature oligodendrocyte cell death: Effect of Bcl-2

Molecular and Cellular Neuroscience

Volumn 22, Issue 4, 2003, Pages 516-529

  FitzGerald, Una F ^a,b   Gilbey, Tom ^a   Brodie, Suzanne ^a   Barnett, Susan C ^a  

^a Department of Neurology ^*  (United Kingdom)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; PROTEIN BCL 2; PROTEIN C FOS; PROTEIN C JUN; PROTEIN D JUN; PROTEIN DERIVATIVE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR EGR 1; TRANSCRIPTION FACTOR FRA 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL LEVEL; CELL PROTECTION; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

EID: 0037398933     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-7431(02)00040-4     Document Type: Article

References (60)

1. Abate C., Patel L., Rauscher F.J. 3rd, Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science. 249:1990;1157-1161.
2. Adams J.M., Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 26:2001;61-66.
3. Alvarez C., Sztul E.S. Brefeldin A (BFA) disrupts the organization of the microtubule and the actin cytoskeletons. Eur. J. Cell Biol. 78:1999;1-14.
4. Angel P., Hattori K., Smeal T., Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell. 55:1988;875-885.
5. Arrigo A.P. Gene expression and the thiol redox state. Free Radicals Biol. Med. 27:1999;936-944.
6. Bae S.K., Bae M.H., Ahn M.Y., Son M.J., Lee Y.M., Bae M.K., Lee O.H., Park B.C., Kim K.W. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Cancer Res. 59:1999;5989-5994.
7. Barnett S.C., Crouch D.H. The effect of oncogenes on the growth and differentiation of oligodendrocyte type 2 astrocyte progenitor cells. Cell Growth Differ. 6:1995;69-80.
8. Benjamin J.A., Nedelkoska L. Maintenance of membrane sheets by cultured oligodendrocytes requires continuous microtubule turnover and Golgi transport. Neurochem. Res. 19:1994;631-639.
9. Bonetti B., Stegagno C., Cannella B., Rizzuto N., Moretto G., Raine C.S. Activation of c-jun and NFκB transcription factors in MS lesions implications for oligodendrocyte pathology . Am. J. Pathol. 155:1999;1433-1438.
10. Bottenstein J., Hayashi I., Hutchings S., Masui H., Mather J., McClure D.B., Ohasa S., Rizzino A., Sato G., Serrero G., Wolfe R., Wu R. The growth of cells in serum free-hormone-supplemented media. Methods Enzymol. 58:1979;94-109.
11. Catania M.V., Copani A., Calogero A., Ragonese G.I., Condorelli D.F., Nicoletti F. An enhanced expression of the immediate early gene, Egr-1, is associated with neuronal apoptosis in culture. Neuroscience. 91:1999;1529-1538.
12. Chakraborty G., Ziemba S., Drivas A., Ledeen R.W. Myelin contains neutral sphingomyelinase activity that is stimulated by tumor necrosis factor-alpha. J. Neurosci. Res. 50:1997;466-476.
13. Denk A., Wirth T., Baumann B. NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival. Cytokine Growth Factor Rev. 11:2000;303-320.
14. Ellerby L.M., Ellerby H.M., Park S.M., Holleran A.L., Murphy A.N., Fiskum G., Kane D.J., Testa M.P., Kayalar C., Bredesen D.E. Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J. Neurochem. 67:1996;1259-1267.
15. FitzGerald U.F., Barnett S.C. AP-1 activity during the growth, differentiation, and death of O-2A lineage cells. Mol. Cell. Neurosci. 16:2000;453-469.
16. Guo H., Tittle T.V., Allen H., Maziarz R.T. Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2. Exp. Cell Res. 245:1998;57-68.
17. Hacki J., Egger L., Monney L., Conus S., Rosse T., Fellay I., Corner C. Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2. Oncogene. 19:2002;2286-2295.
18. Halazonetis T.D., Georgopoulos K., Greenberg M.E., Leder P. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell. 55:1988;917-924.
19. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336.
20. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
21. Huang R.P., Adamson E.D. Characterization of the DNA-binding properties of the early growth response-1 (Egr-1) transcription factor evidence for modulation by a redox mechanism . DNA Cell Biol. 12:1993;265-273.
22. Hughes P.E., Alexi T., Walton M., Williams C.E., Dragunow M., Clark R.G., Gluckman P.D. Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog. Neurobiol. 57:1999;421-450.
23. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesen D.E. Bcl-2 inhibition of neural death decreased generation of reactive oxygen species . Science. 262:1993;1274-1277.
24. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:1997;240-246.
25. Kim Y.S., Kim S.U. Oligodendroglial cell death induced by oxygen radicals and its protection by catalase. J. Neurosci. Res. 29:1991;100-106.
26. Kronke M. Involvement of sphingomyelinases in TNF signalling pathways. Chem. Phys. Lipids. 102:1999;157-166.
27. Kuhlmann T., Lucchinetti C., Zettl U.K., Bitsch A., Lassmann H., Bruck W. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions. Glia. 28:1999;34-39.
28. Larocca J.N., Farooq M., Norton W.T. Induction of oligodendrocyte apoptosis by C2-ceramide. Neurochem. Res. 22:1997;529-534.
29. Lee M., Hyun D.H., Marshall K.A., Ellerby L.M., Bredesen D.E., Jenner P., Halliwell B. Effect of overexpression of BCL-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses, and the proteasome. Free Radicals Biol. Med. 31:2001;1550-1559.
30. Lee W., Mitchell P., Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell. 49:1987;741-752.
31. Levkovitz Y., Baraban J.M. A dominant negative inhibitor of the Egr family of transcription regulatory factors suppresses cerebellar granule cell apoptosis by blocking c-Jun activation. J. Neurosci. 21:2001;5893-5901.
32. Lippincott-Schwartz J., Cole N., Presley J. Unravelling Golgi membrane traffic with green fluorescent protein chimeras. Trends Cell Biol. 8:1998;16-20.
33. Liu C., Calogero A., Ragona G., Adamson E., Mercola D. EGR-1, the reluctant suppression factor EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity . Crit. Rev. Oncog. 7:1996;101-125.
34. Lu F., Selak M., O'Connor J., Croul S., Lorenzana C., Butunoi C., Kalman B. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 177:2000;95-103.
35. Marais R., Wynne J., Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell. 73:1993;381-393.
36. Mayer M., Noble M. N-Acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc. Natl. Acad. Sci. USA. 91:1994;7496-7500.
37. McConkey D.J. Biochemical determinants of apoptosis and necrosis. Toxicol. Lett. 99:1998;157-168.
38. Mercurio F., Manning A.M. Multiple signals converging on NF-kappaB. Curr. Opin. Cell Biol. 11:1999;226-232.
39. Meredith M.J., Cusick C.L., Soltaninassab S., Sekhar K.S., Lu S., Freeman M.L. Expression of Bcl-2 increases intracellular glutathione by inhibiting methionine-dependent GSH efflux. Biochem. Biophys. Res. Commun. 248:1998;458-463.
40. Merrill J.E., Scolding N.J. Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease. Neuropathol. Appl. Neurobiol. 25:1999;435-458.
41. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells AP-1 as secondary antioxidant-responsive factor . EMBO J. 12:1993;2005-2015.
42. Mirkovic N., Voehringer D.W., Story M.D., McConkey D.J., McDonnell T.J., Meyn R.E. Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols. Oncogene. 15:1997;1461-1470.
43. Muthukkumar S., Han S.S., Rangnekar V.M., Bondada S. Role of Egr-1 gene expression in B cell receptor-induced apoptosis in an immature B cell lymphoma. J. Biol. Chem. 272:1997;27987-27993.
44. Perkins N.D. The Rel/NF-kappa B family friend and foe . Trends Biochem. Sci. 25:2000;434-440.
45. Quillet-Mary A., Jaffrezou J.P., Mansat V., Bordier C., Naval J., Laurent G. Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J. Biol. Chem. 272:1997;21388-21395.
46. Rao R.V., Hermel E., Castro-Obregon S., del Rio G., Ellerby L.M., Ellerby H.M., Bredesen D.E. Coupling endoplasmic reticulum stress to the cell death program mechanism of caspase activation . J. Biol. Chem. 276:2001;33869-33874.
47. Richter-Landsberg C., Vollgraf U. Mode of cell injury and death after hydrogen peroxide exposure in cultured oligodendroglia cells. Exp. Cell Res. 244:1998;218-229.
48. Ryseck R.P., Bravo R. c-Jun, Jun B, and Jun D differ in their binding affinities to AP-1 and CRE consensus sequences effect of FOS proteins . Oncogene. 6:1991;533-542.
49. Scurlock B., Dawson G. Differential responses of oligodendrocytes to tumor necrosis factor and other pro-apoptotic agents role of ceramide in apoptosis . J. Neurosci. Res. 55:1999;514-522.
50. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:2002;E131-136.
51. Smith J., Ladi E., Mayer-Proschel M., Noble M. Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc. Natl. Acad. Sci. USA. 97:2000;10032-10037.
52. Smith K.J., Kapoor R., Felts P.A. Demyelination the role of reactive oxygen and nitrogen species . Brain Pathol. 9:1999;69-92.
53. Sock E., Leger H., Kuhlbrodt K., Schreiber J., Enderich J., Richter-Landsberg C., Wegner M. Expression of Krox proteins during differentiation of the O-2A progenitor cell line CG-4. J. Neurochem. 68:1997;1911-1919.
54. Suzuki Y.J., Forman H.J., Sevanian A. Oxidants as stimulators of signal transduction. Free Radicals Biol. Med. 22:1997;269-285.
55. Swirnoff A.H., Apel E.D., Svaren J., Sevetson B.R., Zimonjic D.B., Popescu N.C., Milbrandt J. Nab1, a corepressor of NGFI-A (Egr-1), contains an active transcriptional repression domain. Mol. Cell Biol. 18:1998;512-524.
56. Toone W.M., Morgan B.A., Jones N. BCl-2 and glutathione: that regulate apoptosis. Oncogene. 20:2001;2336-2346.
57. Voehringer D.W. Bcl-2 and glutathione alterations in cellular redox state that regulate apoptosis sensitivity . Free Radicals Biol. Med. 27:1999;945-950.
58. Voehringer D.W., McConkey D.J., McDonnell T.J., Brisbay S., Meyn R.E. Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc. Natl. Acad. Sci. USA. 95:1998;2956-2960.
59. Vollgraf U., Wegner M., Richter-Landsberg C. Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J. Neurochem. 73:1999;2501-2509.
60. Zeine R., Cammer W., Barbarese E., Liu C.C., Raine C.S. Structural dynamics of oligodendrocyte lysis by perforin in culture relevance to multiple sclerosis . J. Neurosci. Res. 64:2001;380-391.